Bromide

Bromide

SCHEMBL16760943

CCCCCCCCCCCCCCCCCCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[Br-]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 1/20 0.56
▸ TRAP1 Q12931 2/20 0.46
▸ CHRNA7 P36544 7/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ DNM1 Q05193 2/20 0.43
▸ CSNK1E P49674 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1866839 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL2979400 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL7759526 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL678415 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL164301 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL635580 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL286882 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL1963378 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Decyltriphenylphosphonium SCHEMBL287291 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2
Bromide SCHEMBL2446607 1.00 HIF1A (0.56) HIF1ATRAP1CHRNA7ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9464105-B2 Hydroxylated KRN7000 analogue and use thereof RIKEN (JP) 2016-10-11 — — US disclosed
US-20150218199-A1 HYDROXYLATED KRN7000 ANALOGUE AND USE THEREOF RIKEN (JP) 2015-08-06 — — US disclosed
EP-2881400-A1 HYDROXYLATED KRN7000 ANALOGUE AND USE THEREOF Riken (JP) 2015-06-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218199-A1 HYDROXYLATED KRN7000 ANALOGUE AND USE THEREOF PHF20, KLF10, AKR1B10 HIF1A 106/4885TRAP1 1915/4885CHRNA7 4005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback